🩺 ANTIEPILEPTICS 🏷️ GABA analogue
👨‍⚕️ Clinically Reviewed by: PakistaniBano Medical Editorial Board (Pharm.D Panel)
📅 Reviewed: November 2026 • 🔍 Authority: DRAP / WHO ATC
📦 Formulations, Pack Sizes & Retail Prices Currency: Rs.
Dosage Form Reg. No Pack Size Trade Price (TP) Maximum Retail Price (MRP)
Cap 150 mg 078182 14 Rs.1026.10 Rs.1207.18
Cap 300 mg 078183 14 Rs.829.47 Rs.975.85
Cap 100 mg 078184 14 Rs.294.83 Rs.346.87

📋 Indications & Clinical Dosage

*Peripheral and central neuropathic pain:* Adult: Initially 150 mg daily in 2-3 divided doses, then increased after 3-7 days if necessary to 300 mg daily in 2-3 divided doses, then increased after 7 days if necessary up to 600 mg daily in 2-3 divided doses. *Adjunctive therapy for focal seizures with or without secondary generalization:* Adult: Initially 25 mg twice daily, then increased at 7 day intervals in steps of 50 mg daily, increased to 300 mg daily in 2-3 divided doses for 7 days, then increased if necessary up to 600 mg daily in 2-3 divided doses. *Generalized anxiety disorder:* Adult: Initially 150 mg daily in 2-3 divided doses, then increased at 7 day intervals in steps of 150 mg daily if required, increased if necessary up to 600 mg daily in 2-3 divided doses.

⚠️ Precautions & Warnings

Conditions that may precipitate encephalopathy, severe congestive heart failure. Avoid abrupt withdrawal (taper over at least 1 week), renal and hepatic impairment.

🔄 Drug Interactions

Oxycodone, ethanol, lorazepam.

⚠️ Adverse Reactions / Side Effects

Aggression, blurred vision, confusion, constipation, diplopia, dizziness, drowsiness, dry mouth, lack in muscle control and movement, euphoria, flatulence, impaired memory and attention, insomnia, irritability, malaise, oedema, paraesthesia, sexual dysfunction, speech disorder, visual disturbances, visual field defects, vomiting, weight gain. Rare: congestive heart failure, convulsions, diarrhoea, encephalopathy, headache, keratitis, nausea, pruritus, QT-interval prolongation, Stevens-Johnson syndrome, suicidal ideation, urinary retention

🤰 Pregnancy & Lactation Safety

Pregnancy Risk:
Avoid unless the potential benefit outweighs the risk.
Lactation / Breastfeeding:
Contraindicated, avoid

📚 Official Regulatory & Clinical References

  • Drug Regulatory Authority of Pakistan (DRAP): Drug Registration, S.R.O. Price Gazettes & National Essential Medicines List (NEML).
  • World Health Organization (WHO): Collaborating Centre for Drug Statistics Methodology (ATC/DDD Index).
  • Formulary Standards: British National Formulary (BNF) & Pakistan National Formulary (PNF) guidelines.

Related Medicines

Medicines related to this brand, grouped by relevance.

Same generic: PREGABALIN

ABALIN
EG PHARMA
Rs.202.00
ABENAKI
MEDAL PHARMA
Rs.304.00
BIOGAB
CIBA PHARMA
Rs.486.07
BREGLIN
BROOKES
Rs.400.00
BRULYN
JENNER PHARMA
Rs.152.00
DOLOGAB
MARTIN DOW MARKER
Rs.420.00

More from LINTA

ABENDA
LINTA
Rs.23.40
ACPRO
LINTA
Rs.207.37 Gel 0.1%(080268)
ACUTIN
LINTA
Rs.108.13

Same category: ANTIEPILEPTICS

ABAPEN
BOSCH
Rs.50.00
AIMGA
AIMS PHARMA
Rs.50.00
AROPEN
HYGEIA
Rs.150.00

⚡ Quick Actions

💬 Share via WhatsApp